Background In the 5 years that have passed since the publication of the 2018 International
Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (ICAR‐Allergic Rhinitis …

Allergen immunotherapy is a cornerstone in the treatment of allergic children. The clinical
efficiency relies on a well‐defined immunologic mechanism promoting regulatory T cells and …

Asthma, rhinitis, and atopic dermatitis (AD) are interrelated clinical phenotypes that partly
overlap in the human interactome. The concept of “one‐airway‐one‐disease,” coined over …

The selection of pharmacotherapy for patients with allergic rhinitis aims to control the
disease and depends on many factors. Grading of Recommendations Assessment …

Allergic rhinitis (AR) is caused by immunoglobulin E (IgE)-mediated reactions to inhaled
allergens and is one of the most common chronic conditions globally. AR often co-occurs …

Background The number of patients affected by allergies is increasing worldwide. The
resulting allergic diseases are leading to significant costs for health care and social systems …

Background Validated combined symptom‐medication scores (CSMSs) are needed to
investigate the effects of allergic rhinitis treatments. This study aimed to use real‐life data …

Randomized controlled trials (RCTs) are the gold‐standard for benefit–risk assessments
during drug approval processes. Real‐word data (RWD) and the resulting real‐world …

Introduction The numerous links between allergic rhinitis and asthma have been extensively
explored in the last two decades, gaining great concern within the scientific community …

MASK‐air®, a validated mHealth app (Medical Device regulation Class IIa) has enabled
large observational implementation studies in over 58,000 people with allergic rhinitis …